Exor NV 2022 AR2
The report highlights Exor's performance in 2022, during which its Net Asset Value (NAV) per share decreased by 7.6%, outperforming the MSCI World Index by 6.6 percentage points. A key milestone was the completion of the sale of PartnerRe to Covéa for €8.6 billion, which significantly increased the company's cash position. Exor also expanded into the healthcare sector by investing €833 million for a 10% stake in Institut Mérieux and acquiring 45% of Lifenet Healthcare. Additionally, the company launched its first climate-related risks and opportunities assessment in line with the TCFD framework and committed to achieving carbon neutrality at the holding level.
Company: Exor NV
Sector: Finance & insurance
Country: Netherlands
Year: 2022
Type: AR2
Pages: 351
Back to company
Exor NV
Annual Report
The report highlights Exor's performance in 2022, during which its Net Asset Value (NAV) per share decreased by 7.6%, outperforming the MSCI World Index by 6.6 percentage points. A key milestone was the completion of the sale of PartnerRe to Covéa for €8.6 billion, which significantly increased the company's cash position. Exor also expanded into the healthcare sector by investing €833 million for a 10% stake in Institut Mérieux and acquiring 45% of Lifenet Healthcare. Additionally, the company launched its first climate-related risks and opportunities assessment in line with the TCFD framework and committed to achieving carbon neutrality at the holding level.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2022
Reporting Period
Jan 1, 2022 - Dec 31, 2022
Fiscal Year
2022
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Women on Board
Women in Management
Net Zero Target
Employees